This inventor holds 7 USPTO granted patents, plus 3 CIPO patents and 1 EPO patent. Top assignees: Mead Johnson Nutrition Company, Bristol-Myers Squibb Compnay. Active years: 1996-2016.
Location History:
- Evansville, IN (US) (1996 - 1997)
- Newburgh, IN (US) (2009 - 2013)
- Westfield, IN (US) (2015)
- Ewing, NJ (US) (2016)
Company Filing History:
5 out of 104 
2 out of 3,736 
Years Active: 1996-2016
Title: Bryon W Petschow: Innovator in Nutritional Science
Introduction
Bryon W Petschow is a notable inventor based in Newburgh, Indiana, recognized for his contributions to nutritional science. He holds a total of 7 patents, showcasing his innovative approach to enhancing infant nutrition and health.
Latest Patents
Among his latest patents, one significant invention is a method for inhibiting the growth of pathogenic bacteria in infant formula. This method involves supplementing the formula with at least one diglyceride antimicrobial agent. Another important patent focuses on adherence inhibition of pathogens by prebiotic oligosaccharides. This invention relates to nutritional compositions that include a prebiotic component designed to inhibit the adherence of pathogens in the gastrointestinal tract. The compositions consist of a fat or lipid source, a protein source, and a carbohydrate source that contains an effective amount of the prebiotic component.
Career Highlights
Bryon has worked with prominent companies in the field, including Mead Johnson Nutrition Company and Bristol-Myers Squibb Company. His experience in these organizations has significantly contributed to his expertise in nutritional innovations.
Collaborations
Throughout his career, Bryon has collaborated with esteemed colleagues such as Robert J McMahon and Robert Rastall. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Bryon W Petschow's innovative work in nutritional science has led to significant advancements in infant health. His patents reflect a commitment to improving dietary formulations and addressing critical health challenges.